Ensuring that blood pressure is recorded accurately

In 2017, the American College of Cardiology and American Heart Association released new hypertension guidelines recommending that we lower our blood pressure targets to 130 over 80. So this means that patients who have hypertension, instead of lowering it to less than 140 over 90 which we’ve done in the past. We’re a little bit…

Help Patients Take Blood Pressure Medicines As Directed

[NARRATOR] One in four new prescriptions for hypertension medications are never filled. A major problem when 70% of U.S. adults over 65 have high blood pressure, and only half of them have it under control. Even hypertensive patients covered by Medicare Part D have high rates of non-adherence, too often skipping doses, taking the wrong…

Advances in Sepsis: Protecting Patients Throughout the Lifespan

>>Good afternoon and welcome to today’s webinar, Advances in Sepsis: Protecting Patients Throughout the Lifespan. My name is Abbigail Tumpey. I’m Associate Director for Communications Science at the Centers for Disease Control and Prevention Division of Healthcare Quality Promotion. This webinar is part of a series of webinars that CDC will be hosting with a…

Drug Company Takes The High Ground On The Benicar Lawsuit

A Japanese drug maker is agreeing to pay up to $300 million to settle 2,000 U.S. cases against them. These cases, which amount to over 2,000, are accusing the company of failing to warn users that its blood pressure medication, Benicar, can cause serious gastrointestinal illness. Joining me to talk about this is Daniel Nigh….

Trauma Center Director Jeff Young, MD

I’m Jeff Young and I’m the director of the trauma center. I take care of mostly injured patients, severely injured patients. I enjoy having to have to think on my feet and react to unfamiliar and kind of chaotic circumstances. I also work with the fire departments and rescue squads here, and trauma allows me…

ESC TV 2015 – Congress by Topic – Hypertension

PATHWAY is a series of trials conducted by the British Hypertension Society investigating the treatment of hypertension, in PATHWAY-2 314 well-characterized resistant hypertensive patients were randomised to receive, in a sequential manner, either spironolactone, an alpha blocker a beta blocker or a placebo, every patient took every drug for 12 weeks We saw that the…